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RESEARCH
Effect of preventive primary care outreach on health related
quality of life amongolder adults at risk of functional decline:
randomised controlled trial
Jenny Ploeg, associate professor,1 Kevin Brazil, professor,2 director,3 Brian Hutchison, professor emeritus,4
Janusz Kaczorowski, associate professor,5 Dawn M Dalby, assistant professor,6 Charles H Goldsmith,
professor emeritus,7,8 William Furlong, research associate9
ABSTRACT
Objective To evaluate the impact of a provider initiated
primary care outreach intervention compared with usual
care among older adults at risk of functional decline.
Design Randomised controlled trial.
Setting Patients enrolled with 35 family physicians in five
primary care networks in Hamilton, Ontario, Canada.
Participants Patients were eligible if they were 75 years of
age or older andwere not receiving home care services. Of
3166 potentially eligible patients, 2662 (84%) completed
the validated postal questionnaire used to determine risk
of functional decline. Of 1724 patients who met the risk
criteria, 769 (45%) agreed to participate and 719 were
randomised.
Intervention The 12 month intervention, provided by
experienced home care nurses in 2004-6, consisted of a
comprehensive initial assessment using the resident
assessment instrument for home care; collaborative care
planning with patients, their families, and family
physicians; health promotion; and referral to community
health and social support services.
Main outcome measures Quality adjusted life years
(QALYs), use and costs of health and social services,
functional status, self rated health, and mortality.
Results The mean difference in QALYs between
intervention and control patients during the study period
was not statistically significant (0.017, 95% confidence
interval −0.022 to 0.056; P=0.388). The mean difference
in overall cost of prescription drugs and services between
the intervention and control groups was not statistically
significant, (−$C165 (£107; €118; $162), 95%
confidence interval −$C16545 to $C16214; P=0.984).
Changes over 12 months in functional status and self
rated health were not significantly different between the
intervention and control groups. Ten patients died in each
group.
Conclusions The results of this study do not support
adoption of this preventive primary care intervention for
this target population of high risk older adults.
Trial registration Clinical trials NCT00134836.
INTRODUCTION
The provision of high quality, comprehensive care for
older adults is becoming increasingly challenging
because of the ageing of society, shortages of health-
care providers, and rising healthcare costs.1 2 These
changes call for the development and evaluation of
practical and cost effective approaches to care for
older adults. Systematic reviews of interventions such
as health assessments, home based support, geriatric
evaluation and management, home based nursing
health promotion, home visits, and preventive home
visits attest to the different approaches evaluated to
date.3-8 The findings from these systematic reviews
have been inconsistent—some have reported benefits,
some have found no evidence of impact, and others
have had mixed findings.
The evidence suggests that interventions such as ger-
iatric evaluation and management should be targeted
at specific groups of older adultsmost likely to benefit.9
Recognised criteria for targeting older adults for such
interventions include advanced age, degree of
functional impairment, and presence of other
conditions.10 However, one systematic review of
home visits to reduce functional decline found that sur-
vival benefits were seen in young-old (72.7-77.5 years)
rather than old-old (80.2-81.6 years) populations.7
Further research is needed to determinewhich compo-
nents of preventive home visits work best in which
groups of older adults.11
This study evaluated one approach to caring for
older adults—preventive primary care outreach.12
We define preventive primary care outreach as proac-
tive, provider initiated care above andbeyonddemand
led routine care, provided in a community primary
care setting, and linked to the usual care system.12 Its
goals are to identify unrecognised problems and peo-
ple at increased risk and to link those people to appro-
priate health and social care. Preventive primary care
outreach involves an initial comprehensive assessment
and individualised follow-up. A preventive approach
based on identifying people at risk and providing early
intervention might help to prevent or delay functional
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decline, promote independence, and control health
and social costs.13 14
Although several primary studies have looked at
preventive primary care outreach interventions with
older people, the findings have been mixed.12 Two of
the investigators for this study (JP, BH) did a meta-
analysis of preventive primary care outreach inter-
ventions with older people.12 The review revealed sev-
eral limitations of studies of such interventions: not
targeting the intervention to frail older adults at risk
of functional decline, not using validated screening
tools, not using a standardised comprehensive assess-
ment tool, not assessing health related quality of life,
not assessing cost effectiveness, and insufficient statis-
tical power.
To overcome these limitations, we did a randomised
controlled trial to evaluate the impact of a preventive
primary care outreach intervention compared with
usual care among adults aged 75 years and older who
were at riskof functional decline.Wehypothesised that
over a one year period patients receiving the preven-
tive primary care outreach intervention compared
with control patientswould havemore quality adjusted
life years, higher functional status and self rated health,
lower mortality, and similar costs of health and social
services.
The intervention was provided to patients of family
physicians who were members of primary care net-
works in Hamilton, Ontario, Canada. Primary care
networks comprise networks of solo and small group
practices of family physicians.15 They differ from the
dominant fee for service model in Ontario by virtue of
enrolling patients and remunerating physicians
through a capitation based blended payment model
that includes fees for preventive care outreach, home
care supervision, and team consultation and bonus
payments for achievement of target levels of influenza
vaccination of seniors, cervical smears, mammogra-
phy, and childhood immunisation.
We chose primary care networks for this study
because they had computerised lists of enrolled patients
and provided primary care to approximately half of the
community’s population at the time of the study. In
2007, primary care networks and health service organi-
sations (another capitation based model) were harmo-
nised to become family health organisations.
METHODS
We used a three stage process to recruit patients: ran-
dom selection of primary care networks until the
required sample size was attained, approaching all
family physicians within the selected primary care net-
work to participate in the study, and screening of
patients who were enrolled with participating family
physicians for their risk of functional decline.
Recruitment of family physician practices
We randomly selected five of eight primary care net-
works to participate in the study. As primary care net-
works were selected, we asked all family physicians
within the primary care network to participate in the
study. Two family physicians who were well known
and respected by their colleagues in the community
assisted with recruitment. Research assistants worked
with staff in the participating physicians’ offices to
identify patients who met the study inclusion criteria.
Screening and recruitment of patients
Weused the Sherbrookepostal questionnaire to screen
patients for risk of functional decline.16 This question-
naire includes six items related to mobility, vision,
hearing, memory, drug use, and living alone. Each
item with a positive response is given a score of 1,
with a minimum scale score of 0 and a maximum of
6. In a similar population, the Sherbrooke postal ques-
tionnaire was shown to have 75% sensitivity, 52% spe-
cificity, and a positive predictive value of 38% for
functional decline.16 Validity was tested by comparing
scores on the initial 29 item instrument with the nur-
sing time required for care (r=0.88).16 In our study, we
mailed theSherbrookepostal questionnairewith a cov-
ering letter from the patient’s family physician fol-
lowed by up to two mailed reminders. We identified
Allocated to intervention group (n=361)
  (singles 277, couples* 84)
Received allocated intervention (n=361)
Allocated to control group (n=358)
  (singles 276, couples* 82)
Patients assessed for eligibility (n=4792)
Did not meet eligibility criteria (n=1626)
Patients sent SPQ (n=3166)
Did not complete SPQ (n=504)
Patients completed SPQ (n=2662)
Did not meet SPQ risk cut-off of 2 or more (n=938)
Patients at risk according to SPQ (n=1724)
Refused to participate (n=955)
Patients consented to participate (n=769)
Randomised (n=719)
Not included as sample size was met (n=50)
Allocation
Completed six month visit (n=353)
  (singles 271, couples 82)
Died (n=5) (singles 3, couples 2)
Dropped out (n=3) (singles 3, couples 0)
Completed six month visit (n=351)
  (singles 271, couples 80)
Died (n=4) (singles 2, couples 2)
Dropped out (n=3) (singles 3, couples 0)
Six month follow-up
Completed 12 month visit (n=330)
  (singles 252, couples 78)
Died (n=10) (singles 8, couples 2)
Dropped out (n=19) (singles 15, couples 4)
Other† (singles 2)
Completed 12 month visit (n=311)
  (singles 243, couples 68)
Died (n=10) (singles 8, couples 2)
Dropped out (n=35) (singles 23, couples 12)
Other† (singles 2)
12 month follow-up
Flow diagram of trial. SPQ=Sherbrooke postal questionnaire. *Numbers refer to individual
patients (for example, n=82 refers to 41 couples). †Two patients in each group died after
12 month visit but did not have 12 month assessment; their missing data were imputed in
analysis
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patients who provided a positive response to at least
two questions (score of 2 or more) as being at risk of
functional decline, and their family physician mailed
them a letter inviting them to participate in the study.
Study participants
Eligible patients were aged 75 years or older, they or
their proxy were able to answer questions in English,
and they resided in the city of Hamilton, Ontario,
Canada. Patients were ineligible if they received
home care services, lived in a nursing home or long
term care home, were identified by their family physi-
cian as needing palliative care, were scheduled for
major elective surgery in the next year, or were
planning to leave the country for more than one
month during the 12 month follow-up period.
Study design
The study was a randomised controlled trial with an
intervention group and a control group receiving
usual care. Research staff assessed patients for eligibil-
ity and informed the statistician (CHG) about eligible
patients to be randomised. We randomised each cou-
ple as a cluster of two and single people as individuals.
We used a 1:1 allocation ratio to allocate individuals or
couples to either the intervention group or the control
group. The sequence of allocations was generated in
blocks of eight or 16 such that the allocation was
balanced in blocks. The random numbers used to
assign the block size and choice of allocation within
blocks came from the Rand tables of random digits.17
The allocation sequence was kept in the locked office
of the statistician and was inaccessible to staff making
decisions about patients’ eligibility. The results of the
allocation were communicated to the person who
arranged for the nurses to visit the appropriate patients
but not to the research assistants collecting outcome
assessments. Research assistants were thus blinded to
group assignment.
Any single patient who was a partner of an already
allocated patient was assigned to the same group as the
first recruited partner of that couple.We defined study
groups for analyses according to the intention to treat
principle. Participants gave written informed consent
before taking part in the study.
Preventive primary care outreach intervention
The 12 month intervention consisted of a comprehen-
sive initial assessment, collaborative care planning,
health promotion, and referral to community health
and social support services. Three experienced home
care nurses delivered the intervention byusing the resi-
dent assessment instrument for home care system,
composed of the minimum dataset for home care and
the client assessment protocols.18 Particular items in
the minimum dataset for home care trigger up to 30
client assessment protocols that identify patients who
could benefit from further evaluation and intervention.
The client assessment protocols include guidelines that
the nurses used for further assessment and care plan-
ning. Patients’ assessments were completed in their
homes at baseline and at six and 12 months and trig-
gered new interventions and recommendations at each
assessment.
Nurses encouraged patients to take an active part in
their health care and worked closely with patients and
their families.Health promotionmaterials given to and
discussed with patients covered safety in the home
including falls prevention, safe drug management,
nutrition, upper and lower body strengthening exer-
cises, colorectal screening, and influenza vaccination.
Nurses provided health education on topics such as
management of chronic diseases (for example, dia-
betes and heart disease) and encouraged the use of cal-
cium and vitamin D supplements.Where appropriate,
Table 1 | Patients’ characteristics at baseline. Values are numbers (percentages) unless stated
otherwise
Characteristics Intervention (n=361) Control (n=358)
Mean (SD) age (years) 81.0 (4.1) 81.3 (4.4)
Female sex 188 (52) 194 (54)
Marital status:
Married, common law 203 (56) 197 (55)
Widowed 133 (37) 124 (35)
Separated, divorced 10 (3) 24 (7)
Single 14 (4) 13 (4)
Not answered 1 0
Education:
Less than primary school 22 (6) 19 (5)
Completed primary school 70 (19) 83 (23)
Some secondary school 109 (30) 96 (27)
Completed secondary school 76 (21) 71 (20)
Some community college 17 (5) 21 (6)
Completed community college 24 (7) 28 (8)
Some university 16 (4) 14 (4)
University degree 27 (8) 26 (7)
Household income:
Below $20 000 74 (21) 74 (21)
$20 000-$39 999 163 (45) 178 (50)
$40 000-$59 999 50 (14) 49 (14)
$60 000-$79 999 17 (5) 11 (3)
$80 000-$99 999 3 (1) 7 (2)
Over $100 000 12 (3) 9 (3)
Refused to answer/missing 42 (12) 30 (8)
Live alone 119 (33) 125 (35)
Born in Canada 213 (59) 220 (61)
Standardisedmini-mental state examscore (out of 30):
Normal (26-30) 283 (78) 288 (80)
Mild cognitive impairment (20-25) 73 (20) 66 (18)
Moderate cognitive impairment (10-19) 4 (1) 4 (1)
Mean (SD) Health Utilities Index Mark 3 0.54 (0.31) 0.51 (0.32)
Missing 13 17
Scores on Sherbrooke postal
questionnaire:
2 147 (41) 145 (41)
3 122 (34) 105 (29)
4 55 (15) 69 (19)
5 31 (9) 28 (8)
6 6 (2) 11 (3)
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nurses discussed stress on caregivers and options for its
relief including nursing home placement. In negotia-
tion with patients and their families, referrals were
made to various community health and support ser-
vices such as home care services, meals on wheels,
and outpatient clinics. In some cases, patients were
assisted in obtaining bathroom equipment and mobi-
lity aids. After each visit, nurses left a card in the home
outlining their interventions and any actions required
by the patient, such as follow-up with their own family
physician.Nursesmonitored and encouraged patients’
adherence to their recommendations through follow-
up phone calls and home visits.
After each home visit, nurses faxed a physician com-
munication form to the patient’s family physician. This
formoutlined the client assessment protocols that were
triggered at the visit, nursing actions taken to tackle any
problems, and areas of follow-up required by the phy-
sician. Nurses worked closely with the physician and
other professionals (such as pharmacist, dietitian, and
physiotherapist) to implement the plan of care.
Outcome measures
The primary outcome measure was quality adjusted
life years (QALYs) with Health Utilities Index Mark
3 health related quality of life utility scores as the qual-
ity adjustment weights.19-25 The Health Utilities Index
Mark 3 is a reliable and valid generic system for mea-
suring comprehensive health status and overall health
related quality of life.23 26 It consists of two basic com-
ponents: a comprehensive classification system for
health status and a utility scoring function. The health
status classification system consists of eight attributes
(vision, hearing, speech, ambulation, dexterity, emo-
tion, cognition, and pain/discomfort), each with five
to six levels, and describes 972 000 unique health
states. The utility scoring function provides a utility
score of health related quality of life for each unique
health state. The utility scores representmeasurements
of community preferences as recommended by many
national guidelines for calculating QALYs for use in
cost effectiveness analyses.26
We chose the QALY as the primary outcome mea-
sure because it integrates twomajor health concerns in
the study population: morbidity and mortality. The
Health Utilities Index Mark 3 comprehensively mea-
sures morbidity across eight attributes/dimensions of
health. Three other intervention studies (two in
Canada and one in the United States) have used health
related quality of life or QALYs (using the Health Uti-
lities Index Mark 3) as a primary or secondary out-
come measure.27-29 Two of these studies found a
statistically significant difference between intervention
and control groups.28 29
The Health Utilities Index Mark 3 questionnaire
asked each respondent about the patient’s health status
during a two week recall period. The utility scale for
health related quality of life is defined such that being
dead has a score of 0.00, perfect health has the maxi-
mum score of 1.00, negative scores are associated with
states considered to be worse than being dead, and the
minimum score is −0.36. Patients who died during the
study period were assigned a utility score of 0.00 for all
subsequent assessment points. To place the baseline
scores of patients in our intervention group (0.54) and
control group (0.51) in context, they can be compared
with the following scores: 0.90 for the general adult
population (mean age 38 years),30 0.75 for the general
older adult population (age 75-89),31 0.60 for adults
(mean age 66 years) with diabetes,32 and 0.50 for adults
(mean age 63 years) with knee osteoarthritis.28
Secondary outcome measures included costs of
health and social services, functional status, self rated
health, andmortality.We included the nursing costs to
deliver the intervention in the total costs. Themeasure-
ment of costs was based on the quantities and unit costs
of health and social services used by each patient. We
used the health and social service utilization survey to
collect data.33 This survey includes items related to a
comprehensive array of service costs (for example, vis-
its to the family physician, hospital admissions, and
home nursing visits) as well as medical procedures
and prescription drugs. Participantswere asked to indi-
cate the number of times they had used each type of
Table 2 | Patients’ outcomes (without multiple imputation of missing values)
Outcome
Intervention Control
Mean (SD) Median (IQR) No Mean (SD) Median (IQR) No
Quality adjusted life years (QALYs)* 0.5554 (0.2621) 0.5876 (0.3557-0.7495) 287 0.5079 (0.2820) 0.5465 (0.2966-0.7368) 267
Cost of prescription drugs† 2440 (2977) 1581 (927-2601) 309 2563 (3016) 1633 (972-2876) 308
Cost of services† 5469 (7330) 3401 (1898-6188) 361 5795 (8758) 3126 (1588-6460) 343
Combined costs of prescription drugs
and services†
7779 (7980) 5558 (3426-8630) 350 8096 (9582) 5089 (3174-9519) 343
Older Americans resources and services
multidimensional functional assessment—
activities of daily living‡§
0.207 (0.922) 0 (0.000-1.000) 328 0.145 (0.817) 0 (0.000-1.000) 310
Self rated health§¶ 0.031 (0.856) 0 (−1.000-1.000) 328 0.068 (0.955) 0 (0.000-1.000) 310
IQR=interquartile range.
*High score is good.
†$CAN including intervention costs for intervention group.
‡High score is good.
§12 month minus baseline.
¶Low score is good.
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resource during the previous six months (hospital
admission, emergency visit, admission to long term
care facility), the previous two weeks (other health
and social services), or the previous four days (pre-
scription drugs and special treatments). We measured
functional status by self report with the five items in the
activities of daily living section of the older Americans
resources and services multidimensional functional
assessment.34 The scoring scale of this measure varies
from a minimum of 5 to a maximum of 15; a lower
score indicates more impaired functional abilities.
We assessed self rated health by using a single item
from the medical outcomes study SF-36, asking
respondents to rate their health on a five category
scale from excellent (1) to poor (5).35 36
All outcomemeasures were assessed at baseline and
12 months. Health Utilities Index Mark 3 and health
and social service utilization survey measurements
were also collected at six months. Research assistants
made home visits to collect outcome data. When
patients had died before the next follow-up visit by
the research assistant, the research assistant obtained
the date of death by contacting the family physician
or a family member. Outcome measurements were
collected between 26 August 2004 and 26 June 2006.
Sample size
Health Utilities Index Mark 3 scores are available for
7600 respondents to the 2000-1 Canadian community
health survey aged 75 years or older. Anticipating that
the Sherbrooke postal questionnaire would identify
approximately 50% of those screened for our study as
being at risk of functional decline, we used the mean
(0.486) and standard deviation (0.277) of Health Utili-
ties Index scores among the Canadian community
health survey respondents 75 years of age or older
whose scores were at or below the median to estimate
the initial Health Utilities Index scores in our sample.
We used data from the 2000-1 Canadian community
health survey and the 1990 Ontario health survey to
estimate the expected decline in Health Utilities
Index scores over 15 months due to ageing (0.02).
(The sample size was originally calculated for a
15month intervention, but wewere only able to offer a
12 month intervention.) We estimated the expected
survival rate among control group participants at
15 months’ follow-up to be 91% on the basis of data
from the control arms of randomised controlled trials
in the meta-analysis of preventive primary care out-
reach interventions.12 Combining these data, we calcu-
lated the expected end of study mean Health Utilities
Index score among control participants to be 0.424.
Given the 20% reduction in mortality attributable to
preventive primary care outreach interventions at
one year follow-up inourmeta-analysis,we anticipated
that themeanHealthUtilities Index score at 15months
among intervention patients would be at least 15%
higher than that among control group patients. On
the basis of an average loss to follow-up of 7.2% in
the preventive primary care outreach trials in the
meta-analysis, we conservatively assumed a 10% loss
to follow-up for our sample size calculations. Setting α
at 0.05 and β at 0.2, we needed to recruit 664 patients
(332 in each group).37
Analysis
We used the Health Utilities Index Mark 3 scores of
health relatedquality of life at baseline, sixmonths, and
12 months to calculate QALYs, using the area under
the curve technique. The health related quality of life
curve consists of horizontal segments for the two week
health status recall periods and straight lines joining
these horizontal segments (that is, a trapezoid estima-
tion rule). When a patient died between assessment
times, we assigned a health related quality of life
score of 0.00 from the date of death and used a straight
line to join the previous health related quality of life
score and this 0.00. For the outcomes of self rated
health and older Americans resources and services
multidimensional functional assessment—activities of
daily living, we calculated the change in scores
(12 month value minus baseline value) for the inter-
vention and control groups.
Webased unit costs for each service andprescription
drug used on means for the province of Ontario,
Canada.38 39 We described use of services in the inter-
vention and control groups by using descriptive statis-
tics (mean, standard deviation, interquartile range) and
Table 3 | Patients’ outcomes, with multiple imputation
Outcome
Difference (intervention
minus control) (95% CI) P value Intraclass correlation
Quality adjusted life years (QALYs)* 0.017 (−0.022 to 0.056) 0.388 0.297
Cost of prescription drugs† −65 (−5849 to 5719) 0.982 0.000
Cost of services† −100 (−14 920 to 14 720) 0.989 0.049
Combined costs of prescription drugs and services† −165 (−16 545 to 16 214) 0.984 0.009
Older Americans resources and services multidimensional functional
assessment—activities of daily living‡§
0.091 (−0.042 to 0.223) 0.180 0.280
Self rated health§¶ −0.015 (−0.158 to 0.127) 0.832 0.110
*High score is good (positive difference estimate favours intervention).
†$CAN including intervention costs for intervention group (negative difference estimate favours intervention).
‡High score is good (positive difference estimate favours intervention).
§12 month value minus baseline value.
¶Low score is good (negative difference estimate favours intervention).
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compared them by using both the Kolmogorov-
Smirnov test and theKuiper test, the first of which gen-
erally has the lower power.40 We used a two tailed
Fisher exact test to compare the number of patients
with a long term care admission. We calculated the
total daily costs of all service and prescription drug
items for each patient at baseline (cost 1), six months
(cost 2), and 12 months (cost 3). We used the formula
((cost 1+cost 2)/2)×182+((cost 2+cost 3)/2)×183 to cal-
culate annual costs for each patient who completed the
study to 365 days. We made adjustments to the calcu-
lation on the basis of date of dropout andmissing data.
We used simple descriptive statistics (mean,median,
standard deviation, interquartile range) to describe the
primary and secondary outcomes for the intervention
and control groups. The estimates of effect forQALYs,
functional status, self rated health, and costs of pre-
scription drugs and services were the difference
between intervention and control groups. We used
analysis of variance to calculate the 95% confidence
intervals and P values for these estimates, recognising
the clustering and blocking in the design, as well as 10
imputations to handle missing data and dropouts from
the study apart from death.
We set statistical significance at the 5% level. Because
of the clustering effect of random allocation by house-
holds, we estimated the intraclass correlations in keep-
ing with the recommendations of Donner and Klar.41
We used SAS software version 9.2 for all analyses.
Multiple imputation analyses
We used multiple imputation to fill in missing data.42
We used the following variables that had few missing
data points to begin the imputation process: sex, mar-
ital status, educational level, baseline self rated health,
randomisation date, six month assessment date, and
12 month assessment date. We created 10 complete
datasets and analysed each separately. We used the
SAS software procedure PROC MIANALYSE to
combine the results of these analyses.
Subgroup analysis
Because we were interested in exploring the differen-
tial effect of the intervention on patients at higher com-
pared with lower risk of functional decline, we did a
post hoc analysis (using two way analysis of variance
and its F tests) of differences in outcomes for patients
who were at greater risk of functional decline (Sher-
brooke postal questionnaire scores of 4-6) compared
with those who were at lower risk of functional decline
(scores of 2-3).
RESULTS
Participant characteristics
Thirty-five (47%) of 74 family physicians agreed to par-
ticipate. Of the 4792 patients aged 75 years and over
enrolled with participating physicians, 1626 did not
meet the inclusion criteria and were not sent the Sher-
brooke postal questionnaire (figure). Of the eligible
patients who were sent the questionnaire, 504/3166
(15.9%) did not complete it. Of the 2662 patients who
completed the questionnaire, 938 (35.2%) scored
below the cut-off score of 2 for risk and were not eligi-
ble to participate. Of the 1724 patients who were eligi-
ble, 955 (55.4%) refused to participate. Between 5
August 2004 and 31 May 2005, we randomised 719
patients. Of the 719 randomised patients, 641 (89.2%)
were assessed at 12 months. Characteristics of patients
in the intervention and control groups were similar
(table 1). The follow-up rate at 12 months was 91%
(330/361) in the intervention group and 87% (311/
358) in the control group.
Intervention
The number and frequency of home visits varied
according to the needs of each patient. Themean num-
ber of home visits per patient was 3.03 (minimum 1;
maximum7), indicating thatmost patients received the
planned three home visits over the year. Patients
received a mean of 1.17 telephone calls from the
Table 4 | Number of visits per patient without multiple imputation of missing values
Visits
Intervention Control
Pvalue (KS;Kuiper)*Mean (SD) Median (IQR) No Mean (SD) Median (IQR) No
Family physician† 7.93 (10.49) 0 (0-13) 331 8.51 (10.43) 0 (0-13) 313 0.897; 0.989
Hospital admissions 0.29 (0.66) 0 (0-0) 331 0.49 (1.50) 0 (0-1) 311 0.893; 1.00
Emergency room 0.44 (0.90) 0 (0-1) 331 0.66 (1.19) 0 (0-0) 312 0.085; 0.452
Nursing† 5.04 (23.80) 0 (0-0) 330 2.68 (22.20) 0 (0-0) 310 0.658; 0.986
Specialist† 6.58 (11.12) 0 (0-13) 330 6.29 (10.75) 0 (0-13) 310 1.000; 1.000
Physiotherapy† 2.72 (12.01) 0 (0-0) 330 3.15 (13.89) 0 (0-0) 310 1.000; 1.000
Occupational therapy† 0.83 (4.84) 0 (0-0) 330 0.34 (3.45) 0 (0-0) 310 0.999; 1.000
Social worker† 0.24 (2.25) 0 (0-0) 330 0.46 (3.96) 0 (0-0) 310 1.000; 1.000
Nutritionist† 0.39 (2.65) 0 (0-0) 330 0.34 (2.07) 0 (0-0) 310 1.000; 1.000
Homemaker† 3.62 (23.25) 0 (0-0) 330 3.73 (23.89) 0 (0-0) 310 1.000; 1.000
No(%)patientswithlong
term care admission
7/331 (2.1) 11/314 (3.5) 0.343‡
IQR=interquartile range.
*Because distributions are heavily skewed and assumption of normality was violated, two non-parametric tests were used to compare intervention
and control groups: Kolmorgorov-Smirnov (KS) test and Kuiper test.
†Values estimated on basis of reported visits during previous two weeks at six month and 12 month assessments.
‡Fisher’s exact test.
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nurse in addition to the home visits over the year.
Referrals were most often made to the regional home
care agency and the family physician.
Primary outcome measure
The mean QALYs for the intervention and control
group, without multiple imputation, were 0.5554 (SD
0.2621) and 0.5079 (SD 0.2820). Tables 2 and 3 show
outcomes without and with imputation of missing
values. The difference in QALYs (intervention group
minus control group), with multiple imputation, was
not statistically significant (0.017, 95% confidence
interval −0.022 to 0.056; P=0.388).
The mean unimputedHealth Utilities IndexMark 3
scores for intervention and control groups from which
QALYs were derived were as follows. Baseline scores
were 0.54 (SD 0.31, n=348) in the intervention group
and 0.51 (SD 0.32, n=341) in the control group. Six
month scores were 0.55 (SD 0.31, n=327) in the inter-
vention group and 0.50 (SD 0.32, n=316) in the control
group. Twelve month scores were 0.49 (SD 0.31,
n=318) in the intervention group and 0.47 (SD 0.32,
n=302) in the control group.
Secondary outcome measures
We found no statistically significant differences
between the two groups in the costs of prescription
drugs (P=0.982), health and social services (P=0.989),
or prescription drugs and health and social services
combined (P=0.984). The mean total cost for services
and prescription drugs (table 3) used by the inter-
vention group over the year was approximately
$C165 (£107; €118; $162) less than that for the control
group; the data were highly skewed. The mean, stan-
dard deviation, and interquartile range of visits to the
family physician, physician specialist, emergency
roomvisits, and hospital admissions were fairly similar
in the two groups (table 4). Similarly, the number of
visits for physiotherapy and occupational therapy and
visits by social workers, nutritionists, and homemakers
were similar in the two groups. The number of patients
who were admitted to a long term care home was
similar in the intervention (2.1%) and control (3.5%)
groups.
Table 5 shows baseline and 12month scores for self
rated health and functional status by group. We found
no statistically significant differences in change (
12 month minus baseline) in functional status
(P=0.180) or self rated health (P=0.832) between the
intervention and control groups (table 3). Ten patients
in each group died during the 12 month study period.
We found a QALY difference of 0.017 in our study,
and given our actual sample size we had a power of
0.11 to detect a difference of that magnitude. The
observed QALY difference of 0.017 is about 27% of
the effect we anticipated of 0.064.
Subgroup analysis
We did analyses to assess for a differential effect of the
interventiononpatients at higher comparedwith lower
risk of functional decline. Table 6 shows the mean,
median, standard deviation, and interquartile range
of QALYs for patients who were at higher risk of func-
tional decline (Sherbrooke postal questionnaire scores
4-6) and those who were at lower risk of functional
decline (scores 2-3) in each group. The results of an
analysis of variance (table 7) show that no interaction
existed between the risk groups and the treatment
effect (P=0.671), no overall treatment effect occurred
(P=0.989), and the low risk group had higher QALYs
than did the high risk group (P=0.003). However, we
found no significant treatment effect for either the low
risk group (P=0.291) or the high risk group (P=0.565).
DISCUSSION
In this studywe foundno effect of a preventive primary
care outreach intervention for older adults at risk of
functional decline on QALYs, costs of health and
social services, functional status, self rated health, or
mortality. This is a cost neutral intervention that may
produce, at most, small health benefits. We found no
differential effect of the intervention on QALYs for
patients at higher or lower risk of functional decline.
Table 5 | Baseline and 12 month scores for self rated health item from SF-36 and older Americans resources and services
multidimensional functional assessment—activities of daily living. Values are numbers (percentages)
Baseline 12 month
Control (n=358) Intervention (n=361) Control (n=310) Intervention (n=328)
Self rated health item from SF-36
Excellent 24 (7) 21 (6) 20 (6) 16 (5)
Very good 81 (23) 69 (19) 66 (21) 65 (20)
Good 125 (35) 140 (39) 120 (39) 130 (40)
Fair 93 (26) 112 (31) 72 (23) 99 (30)
Poor 35 (10) 19 (5) 32 (10) 18 (5)
Older Americans resources and services multidimensional functional assessment—activities of daily living
Excellent-good 81 (23) 75 (21) 71 (23) 66 (20)
Mild impairment 156 (44) 171 (47) 114 (37) 121 (37)
Moderate impairment 87 (24) 78 (22) 86 (28) 90 (27)
Severe impairment 21 (6) 23 (6) 23 (7) 28 (9)
Total impairment 13 (4) 14 (4) 16 (5) 23 (7)
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Study strengths and limitations
Our study has several strengths that overcome the lim-
itations of previous studies of such interventions. We
used a validated postal questionnaire to determine risk
of functional decline and included only participants
aged 75 years and over who were at risk of functional
decline. We assessed QALYs with an internationally
used and well validated tool and assessed the use and
cost of health and social services three times.Weused a
comprehensive andwidely used assessment tool,mini-
mumdataset for home care, as part of the intervention.
Participants who were randomised had a high comple-
tion rate of 89%overall, 87% in the intervention group,
and 91% in the control group. The distribution of
potential confounding variables was similar between
groups. The inclusion of intraclass correlations in our
results may be valuable for planners of future studies
with similar outcome measures in mixtures of older
couples and singles.
Of eligible patients who completed the Sherbrooke
postal questionnaire and were assessed to be at risk of
functional decline, 55% did not agree to participate in
the study. We do not know if these patients who
refused to participate were similar to the participants
for the variables assessed. Our sample size calculation
was based on an expected annualmortality of 9% in the
control group, and mortality was 2.8% in our study.
Because the baseline Health Utilities Index Mark 3
scores were higher than anticipated and showed a
smaller than expected decline over the 12 months of
the study, the ability of patients to benefit from the
study intervention may have been reduced. The var-
iance inflation on QALYs was relatively high (30%)
owing to clustering (intraclass correlation=0.297 in
table 3). Given that the mortality was lower than
expected and the variance inflation on QALYs was
larger than expected, we had less power than anti-
cipated to rule out small but potentially important dif-
ferences in quality adjusted length of life. The mean
difference in QALYs between the intervention and
control groups in our study, 0.017, is equivalent to six
quality adjusted life days. We collected data related to
use and costs of health and social services indirectly
through reporting by patients.
Comparison with previous studies
Given the inconsistent results from published rando-
mised controlled trials of similar interventions, our
results are both consistent and inconsistent with pre-
vious literature. Our results are consistent with Cana-
dian studies of similar interventions that found no
differences between intervention and control groups in
mortality,43-46 functional ability or decline,44-46 admis-
sion to an institution,43-45 health service use,43 and
expenditures.46Our results are also consistentwith sys-
tematic reviews of randomised controlled trials of pre-
ventive home visits to older adults that found no
difference in mortality,8 functional ability or decline,4
and admission to hospital.4
Our results were in contrast to other reviews of ran-
domised controlled trials of similar interventions that
found lowered mortality, fewer admissions to long
term care, and increased likelihood of living in the
community in the intervention group compared with
the control group.4 12 Although the differences in find-
ings may have been due to the shorter or less intense
intervention of three home visits over one year or the
inclusion of patients who were perhaps more healthy,
the literature is not consistent with this interpretation.
A systematic review of seven intensive home visiting
programmes (at least four visits a year for at least
12 months) for older people with poor health status
found that they were not beneficial in the healthcare
settings of Western countries.47
A recent Canadian study of three payment models
for primary care physicians (primary care networks,
community health centres, and fee for service) in the
management of hypertension found no significant dif-
ferences between the three models of care in physi-
cians’ sex or mean age, urban versus rural practice,
academic versus community practice, and mean num-
ber of physicians per practice.48 No statistically signifi-
cant differences existed between the three models of
care in patients’ age, sex, and socioeconomic status.
Although the mean rate of screening for hypertension
was similar across models of care, the mean rate of
treatment was higher in primary care networks and
fee for service models.
One plausible explanation for our results, given the
universal access to hospital and physician services
under the Canada Health Act and the well established
primary healthcare system in Canada, is that the
patients in the practices included in our study were
Table 6 | HUI-3 QALYs by Sherbrooke postal questionnaire risk score and comparison group
Sherbrooke postal questionnaire
risk score
Intervention Control
Mean (SD) Median (IQR) No Mean (SD) Median (IQR) No
Low (scores 2-3) 0.598 (0.242) 0.624 (0.449-0.779) 224 0.571 (0.258) 0.597 (0.406-0.779) 193
High (scores 4-6) 0.404 (0.276) 0.440 (0.148-0.627) 63 0.342 (0.277) 0.337 (0.149-0.552) 74
IQR=interquartile range.
Table 7 | Subgroup analysis of QALYs by high and low risk subgroups on the Sherbrooke
postal questionnaire
Effect Estimate (95% CI) P value
Treatment 0.000 (−0.068 to 0.067) 0.989
Sherbrooke −0.214 (−0.353 to −0.075) 0.003
Treatment*Sherbrooke interaction 0.047 (−0.170 to 0.263) 0.671
Treatment (for low risk Sherbrooke) 0.023 (−0.020 to 0.067) 0.291
Treatment (for high risk Sherbrooke) 0.023 (−0.055 to 0.100) 0.565
Treatment=intervention minus control; Sherbrooke=high minus low; analyses used were analysis of variance
and its F tests.
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already receiving key services that they needed and
that, as a consequence, the intervention did not pro-
vide an incremental health benefit. Furthermore,
given the financial incentives available to physicians
in primary care networks, and research indicating
that these physicians have higher treatment rates (at
least for hypertension48) than do physicians in other
primary care models, the physicians we selected for
our study may have already been providing compre-
hensive care to their patients and the addition of the
nurse led intervention may thus have had limited
potential to provide additional benefit. Although we
may have expected that the intervention would lead
to increased use of physiotherapy, social work, nutri-
tionist, and homemaker services in the intervention
group, results indicate similar usage in the control
group, suggesting that the control group was already
receiving appropriate levels of services through the
healthcare system.
The baseline Health Utilities Index Mark 3 score of
0.53 for all patients is similar to the utility score of 0.538
found for adults with stroke and much lower than the
score of 0.75 found for a general population of adults
aged 75 to 89 years,30 31 indicating important health
related quality of life deficits among our study group.
This supports the ability of the Sherbrookepostal ques-
tionnaire to identify patients with important health
related quality of life deficits.16
Controversy exists in the literature as to whether
such interventions result in better outcomes for older,
more frail adults compared with younger, less frail
people.7 The post hoc analysis of QALYs found no
significant effect of the intervention for patients with
either high or low Sherbrooke postal questionnaire
scores for risk of functional decline.
Conclusions and policy implications
On the basis of our findings and the related literature,
insufficient evidence exists to justify widespread adop-
tion of this intervention in primary health care for this
target population of older Canadian adults. Future
research could examine the impact of this intervention
in other countries, as Canada has a well established
primary healthcare system in place. Future research
could also assess other patient related variables such
as depression, as this is one of the best predictors of
negative outcomes in older adults.
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